Ignite Creation Date:
2024-05-06 @ 2:18 AM
Last Modification Date:
2024-10-26 @ 11:16 AM
Study NCT ID:
NCT02013154
Status:
COMPLETED
Last Update Posted:
2023-11-01
First Post:
2013-12-11
Brief Title:
A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab
Sponsor:
Leap Therapeutics Inc
Organization:
Leap Therapeutics Inc
Organization Data
Organization:
Leap Therapeutics Inc
Class:
INDUSTRY
Study ID:
DEK-DKK1-P102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Leap Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |